Last year we organised the New Approaches to the Treatment of Parkinson’s Disease meeting (you can read the report here ), this proved to be an outstanding success. We are now in the process of organising a follow up meeting with a broader remit.

A recent study estimated that over 70 million people worldwide are affected by neurodegenerative diseases. For many diseases, current treatments only address symptoms and do not alter disease progression, whilst these treatments can be very helpful there is an urgent need for disease modifying therapies. Over the last few years we have seen significant advances in our understanding of the underlying biology, identification of new therapeutic targets and the design of novel drug candidates. This meeting will highlight leading edge research in the design and development of new therapeutics.

The BMCS New Approaches to Neurodegenerative Diseases meeting will be at Wellcome Genome Campus, Hinxton, Saffron Walden CB10 1RQ on Monday 5th – Tuesday 6th April, 2027.

You can find more details on the website https://www.rscbmcs.org/events/neuro27/ which will be regularly updated.

Abstract submission is now open, the submission link is on the website.

The deadline for oral abstract submission is Midnight (GMT), Monday 14th December, 2026.
The deadline for poster abstract submission is Midnight (GMT), Monday 1st February, 2027.